Thangaraj SS, Oxlund CS, Fonseca MPD, Svenningsen P, et al. The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-[gamma] and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension. J Hypertens 2021 Aug 23. pii: 00004872-900000000-96579.
PMID: 34843183